Sailash I. Patel
Direktor/Vorstandsmitglied bei Meryx, Inc.
Profil
Sailash I.
Patel is currently a Director at Meryx, Inc. Previously, he worked as the VP-Strategic Development & Head-Investor Relations at Furiex Pharmaceuticals, Inc. from 2010 to 2013.
He also served as the Chief Operating Officer at Kinnate Biopharma, Inc. Mr. Patel completed his undergraduate degree at The University of Nottingham and holds an MBA from The University of North Carolina at Charlotte.
Aktive Positionen von Sailash I. Patel
| Unternehmen | Position | Beginn |
|---|---|---|
Meryx, Inc.
 Meryx, Inc. Pharmaceuticals: MajorHealth Technology Meryx, Inc. operates as an immune-oncology company. It focuses on developing drugs that inhibit tumor growth and initiate anti-tumor immunity in a range of cancer, such as leukemia, lung cancer, and melanoma. The company was founded by Doug Graham, Shelley Earp, and Stephen Frye in 2007 and is headquartered in Chapel Hill, NC. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Sailash I. Patel
| Unternehmen | Position | Ende |
|---|---|---|
| KINNATE BIOPHARMA INC. | Geschäftsführer | - |
| FURIEX PHARMACEUTICALS INC | Finanzdirektor/CFO | - |
Ausbildung von Sailash I. Patel
| The University of Nottingham | Undergraduate Degree |
| The University of North Carolina at Charlotte | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Furiex Pharmaceuticals, Inc.
 Furiex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Furiex Pharmaceuticals, Inc. operates as a drug development collaboration company that uses innovative clinical development design to accelerate and increase value of drug development programs by advancing them through the drug discovery and development process in a cost-efficient manner. Its drug development programs are designed and driven by a core team with extensive drug development experience. Furiex Pharmaceuticals was founded in 1998 and is headquartered in Morrisville, NC. | Health Technology |
Meryx, Inc.
Meryx, Inc. Pharmaceuticals: MajorHealth Technology Meryx, Inc. operates as an immune-oncology company. It focuses on developing drugs that inhibit tumor growth and initiate anti-tumor immunity in a range of cancer, such as leukemia, lung cancer, and melanoma. The company was founded by Doug Graham, Shelley Earp, and Stephen Frye in 2007 and is headquartered in Chapel Hill, NC. | Health Technology |
Kinnate Biopharma, Inc.
 Kinnate Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Kinnate Biopharma, Inc. operates as a biopharmaceutical company engaged in the research and development of Kinnate Discovery Engine that targets genomic drivers of cancer. The company was founded by Stephen W. Kaldor and Eric A. Murphy in January 2018 and is headquartered in San Diego, CA. | Health Technology |
